Predictmedix AI Announces Closing of $460,150 First Tranche

Executive Summary

• Predictmedix AI Inc. closed the first tranche of a non‑brokered private placement, issuing 9,203,000 units at $0.05 per unit for gross proceeds of $460,150.
• Each unit consists of one common share and half of a common‑share purchase warrant (exercise price C$0.15, 36‑month term); warrants may be accelerated if the CSE price reaches $0.30 for ten consecutive trading days.
• Insiders purchased $60,000 of the tranche ($30,000 each by Sheldon Kales and Dr. Rahul Kushwah), constituting a related‑party transaction exempted under MI 61‑101; all securities are subject to a statutory hold period of four months and one day.

Key Details

• Units Issued: 9,203,000
• Issue Price: $0.05 per unit
• Gross Proceeds: $460,150
• Insider Participation: $60,000 (Sheldon Kales – $30,000; Dr. Rahul Kushwah – $30,000)
• Unit Composition: 1 common share + ½ warrant per unit
• Warrant Terms:
• Exercise price: C$0.15 per half‑share
• Expiration: 36 months after closing date
• Acceleration clause: If, ≥4 months + 1 day post‑closing, the VWAP on the CSE is ≥ $0.30 for any 10 consecutive trading days, the company may give written notice to accelerate expiry to 30 days after such notice.
• Regulatory Exemption: Transaction qualifies for MI 61‑101 exemption; insider participation does not exceed 25 % of market capitalization.
• Statutory Hold Period: Four months and one day from issuance date for all securities issued in the placement.
• Strategic Context: Financing follows recent European investor outreach, including participation in the 25th MK Investment Conference in Munich and a prior road‑show targeting family offices and institutional investors.

Notable Quotes

(No direct CEO/President quotes were included in the release.)